Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Nándor Ács, Ferenc Bánhidy, Erzsébet H. Puhó & Andrew E. Czeizel. (2009) A possible association between maternal dyspepsia and congenital rectal/anal atresia/stenosis in their children: a population-based case–control study. Acta Obstetricia et Gynecologica Scandinavica 88:9, pages 1017-1023.
Read now
Read now
Per G. Farup, Per O. Vandvik & Lars Aabakken. (2005) How useful are the Rome II criteria for identification of upper gastrointestinal disorders in general practice?. Scandinavian Journal of Gastroenterology 40:11, pages 1284-1289.
Read now
Read now
Articles from other publishers (35)
Kenneth R. DeVault & Sami R. Achem. 2021. The Esophagus. The Esophagus
804
853
.
Hitomi Ichikawa, Mitsushige Sugimoto, Ken Sugimoto, Akira Andoh & Takahisa Furuta. (2016) Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis. Journal of Gastroenterology and Hepatology 31:4, pages 716-726.
Crossref
Crossref
Christiane Bergamasco, Lilian Mika Horie, Raquel Susana Torrinhas & Dan L. Waitzberg. (2014) High‐Fiber Orange Juice as a Nutrition Supplement in Women. Journal of Parenteral and Enteral Nutrition 39:8, pages 941-947.
Crossref
Crossref
M. Vardi, B. L. Cryer, M. Cohen, A. Lanas, T. J. Schnitzer, P. Lapuerta, M. A. Goldsmith, L. Laine, G. Doros, Y. Liu, A. I. McIntosh, C. P. Cannon & D. L. Bhatt. (2015) The effects of proton pump inhibition on patient‐reported severity of dyspepsia when receiving dual anti‐platelet therapy with clopidogrel and low‐dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial. Alimentary Pharmacology & Therapeutics 42:3, pages 365-374.
Crossref
Crossref
Yasuhiro Fujiwara, Yasuki Habu, Kiyoshi Ashida, Motoyasu Kusano, Kazuhide Higuchi & Tetsuo Arakawa. (2013) Sleep Disturbances and Refractory Gastroesophageal Reflux Disease Symptoms in Patients Receiving Once-Daily Proton Pump Inhibitors and Efficacy of Twice-Daily Rabeprazole Treatment. Digestion 88:3, pages 145-152.
Crossref
Crossref
Yukie Kohata, Yasuhiro Fujiwara, Hirohisa Machida, Hirotoshi Okazaki, Hirokazu Yamagami, Tetsuya Tanigawa, Kenji Watanabe, Toshio Watanabe, Kazunari Tominaga & Tetsuo Arakawa. (2012) Pathogenesis of proton‐pump inhibitor‐refractory non‐erosive reflux disease according to multichannel intraluminal impedance‐pH monitoring. Journal of Gastroenterology and Hepatology 27:s3, pages 58-62.
Crossref
Crossref
Kenneth R. DeVault & Sami R. Achem. 2012. The Esophagus. The Esophagus
782
813
.
Michio Hongo. (2011) Epidemiology of FGID symptoms in Japanese general population with reference to life style. Journal of Gastroenterology and Hepatology 26, pages 19-22.
Crossref
Crossref
Feng Li & Cuong C. Nguyen. 2010. Practical Gastroenterology and Hepatology: Liver and Biliary Disease. Practical Gastroenterology and Hepatology: Liver and Biliary Disease
105
112
.
H. BEAUMONT, A. SMOUT, M. AANEN, H. RYDHOLM, A. LEI, A. LEHMANN, M. RUTH & G. BOECKXSTAENS. (2009)
The GABA
B
receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study
. Alimentary Pharmacology & Therapeutics 30:9, pages 937-946.
Crossref
Crossref
Hanneke Beaumont & Guy E E Boeckxstaens. (2009) Does the Presence of a Hiatal Hernia Affect the Efficacy of the Reflux Inhibitor Baclofen During Add-On Therapy?. The American Journal of Gastroenterology 104:7, pages 1764-1771.
Crossref
Crossref
H. Piessevaux, B. De Winter, E. Louis, V. Muls, D. De Looze, P. Pelckmans, M. Deltenre, D. Urbain & J. Tack. (2009) Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterology & Motility 21:4, pages 378-388.
Crossref
Crossref
H Beaumont, J Jensen, A Carlsson, M Ruth, A Lehmann & GE Boeckxstaens. (2008)
Effect of Δ
9
‐tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans
. British Journal of Pharmacology 156:1, pages 153-162.
Crossref
Crossref
T. HERSHCOVICI & J. ZIMMERMAN. (2008) Nondigestive symptoms in non‐erosive reflux disease: nature, prevalence and relation to acid reflux. Alimentary Pharmacology & Therapeutics 28:9, pages 1127-1133.
Crossref
Crossref
Yuji Amano, Haruhiro Yamashita, Kenji Koshino, Tadayuki Ohshima, Hiroto Miwa, Ryuichi Iwakiri, Kazuma Fujimoto, Noriaki Manabe, Ken Haruma & Yoshikazu Kinoshita. (2008) Does magnifying endoscopy improve the diagnosis of erosive esophagitis?. Journal of Gastroenterology and Hepatology 23:7pt1, pages 1063-1068.
Crossref
Crossref
Mohammad J Ehsani, Iradj Maleki, Fatemeh Mohammadzadeh & Ameneh Mashayekh. (2007) Epidemiology of gastroesophageal reflux disease in Tehran, Iran. Journal of Gastroenterology and Hepatology 22:9, pages 1419-1422.
Crossref
Crossref
Mohammadreza Rezailashkajani, Delnaz Roshandel, Sepideh Shafaee & Mohammad Reza Zali. (2007) High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients. European Journal of Gastroenterology & Hepatology 19:6, pages 499-506.
Crossref
Crossref
A. FRASER, B. C. DELANEY, A. C. FORD, M. QUME & P. MOAYYEDI. (2007) The Short‐Form Leeds Dyspepsia Questionnaire validation study. Alimentary Pharmacology & Therapeutics 25:4, pages 477-486.
Crossref
Crossref
Sarah N. Flier & Suzanne Rose. (2006) Is Functional Dyspepsia of Particular Concern in Women? A Review of Gender Differences in Epidemiology, Pathophysiologic Mechanisms, Clinical Presentation, and Management. The American Journal of Gastroenterology 101:s3, pages S644-S653.
Crossref
Crossref
Eric M. Ward, Herbert C. Wolfsen, Sami R. Achem, David S. Loeb, Murli Krishna, Lois L. Hemminger & Kenneth R. DeVault. (2006) Barrett's Esophagus Is Common in Older Men and Women Undergoing Screening Colonoscopy Regardless of Reflux Symptoms. The American Journal of Gastroenterology 101:1, pages 12-17.
Crossref
Crossref
Yasuhiro Fujiwara, Ai Machida, Yoko Watanabe, Masatsugu Shiba, Kazunari Tominaga, Toshio Watanabe, Nobuhide Oshitani, Kazuhide Higuchi & Tetsuo Arakawa. (2005) Association Between Dinner-to-Bed Time and Gastro-Esophageal Reflux Disease. The American Journal of Gastroenterology 100:12, pages 2633-2636.
Crossref
Crossref
R. JONES & J. P. GALMICHE. (2005) Review: What do we mean by GERD? – definition and diagnosis. Alimentary Pharmacology & Therapeutics 22:s1, pages 2-10.
Crossref
Crossref
P. MOAYYEDI & A. T. R. AXON. (2005) Review article: gastro‐oesophageal reflux disease – the extent of the problem. Alimentary Pharmacology & Therapeutics 22:s1, pages 11-19.
Crossref
Crossref
Y. Fujiwara, K. Higuchi, H. Nebiki, S. Chono, H. Uno, K. Kitada, H. Satoh, K. Nakagawa, K. Kobayashi, K. Tominaga, T. Watanabe, N. Oshitani & T. Arakawa. (2005) Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non‐erosive gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 21:s2, pages 10-18.
Crossref
Crossref
Yasuhiro Fujiwara, Kazuhide Higuchi, Masatsugu Shiba, Kazuki Yamamori, Yoko Watanabe, Eiji Sasaki, Kazunari Tominaga, Toshio Watanabe, Nobuhide Oshitani & Tetsuo Arakawa. (2005) Differences in Clinical Characteristics between Patients with Endoscopy-Negative Reflux Disease and Erosive Esophagitis in Japan. The American Journal of Gastroenterology 100:4, pages 754-758.
Crossref
Crossref
J. Y. Kang. (2005) Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 21:6, pages 663-676.
Crossref
Crossref
Adam Fraser, Brendan Delaney & Paul Moayyedi. (2005) Symptom-Based Outcome Measures for Dyspepsia and GERD Trials: A Systematic Review. The American Journal of Gastroenterology 100:2, pages 442-452.
Crossref
Crossref
YASUHIRO FUJIWARA, KAZUHIDE HIGUCHI, YOKO WATANABE, MASATSUGU SHIBA, TOSHIO WATANABE, KAZUNARI TOMINAGA, NOBUHIDE OSHITANI, TAKAYUKI MATSUMOTO, HIDEKI NISHIKAWA & TETSUO ARAKAWA. (2009) Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. Journal of Gastroenterology and Hepatology 20:1, pages 26-29.
Crossref
Crossref
B. C. Delaney. (2004) Review article: prevalence and epidemiology of gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 20:s8, pages 2-4.
Crossref
Crossref
J. Zimmerman. (2004) Irritable bowel, smoking and oesophageal acid exposure: an insight into the nature of symptoms of gastro‐oesophageal reflux. Alimentary Pharmacology & Therapeutics 20:11-12, pages 1297-1303.
Crossref
Crossref
J. Y. Kang. (2004) Geographical and ethnic differences in gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 20:7, pages 705-717.
Crossref
Crossref
H. B. El‐Serag & N. J. Talley. (2004) The prevalence and clinical course of functional dyspepsia. Alimentary Pharmacology & Therapeutics 19:6, pages 643-654.
Crossref
Crossref
. (2003) Ultrathin endoscopy without sedation: is this the future of esophagology?. The American Journal of Gastroenterology 98:11, pages 2342-2344.
Crossref
Crossref
H. B. El‐Serag & N. J. Talley. (2003) Health‐related quality of life in functional dyspepsia. Alimentary Pharmacology & Therapeutics 18:4, pages 387-393.
Crossref
Crossref
V Nathoo. (2001) MANAGING GASTRO‐OESOPHAGEAL REFLUX DISEASE IN PRIMARY CARE. International Journal of Clinical Practice 55:7, pages 465-469.
Crossref
Crossref